FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Bid/Ask 15:46:40 2024-05-22 EDT | ||
| 11.16 EUR | -3.71% |
|
| Current month | +42.73% | ||
| 1 month | +44.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 11.16 | -3.71% |
| 24-05-21 | 11.59 | +1.05% |
| 24-05-20 | 11.47 | +1.15% |
| 24-05-17 | 11.34 | -2.83% |
| 24-05-16 | 11.67 | -3.31% |
Real-time Boerse Frankfurt Warrants
Last update May 22, 2024 at 03:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01G1 |
| ISIN | DE000SB01G18 |
| Date issued | 2020-06-09 |
| Strike | 225.5 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.73 € |
|---|---|
| Lowest since issue | 4.74 € |
| Spread | 0.03 € |
| Spread % | 0.27% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
314.8
USD
Average target price
316.1
USD
Spread / Average Target
+0.39%
- Stock Market
- Certificates
- Certificat
